Skip to main content
Advanced Enzyme Technologies Limited logo

Advanced Enzyme Technologies Limited — Investor Relations & Filings

Ticker · ADVENZYMES ISIN · INE837H01020 LEI · 335800PWJRERMBTUUV90 BSE.NS Manufacturing
Open in API
Filings indexed 938 across all filing types
Latest filing 2024-11-04 Regulatory Filings
Country IN India
Listing BSE.NS ADVENZYMES

About Advanced Enzyme Technologies Limited

https://www.advancedenzymes.com/

Advanced Enzyme Technologies Limited is a research-driven company specializing in the development, manufacturing, and marketing of proprietary enzyme products and probiotics. The company operates across the entire enzyme value chain, from research and development to commercial-scale production. Its diverse portfolio serves multiple sectors, including human nutrition, animal nutrition, and industrial processing. Key applications encompass food and beverage production, dietary supplements, animal feed additives, and various industrial processes such as textiles, detergents, and pulp and paper manufacturing. With a focus on biotechnology and sustainable solutions, the firm leverages its extensive R&D capabilities to provide customized enzyme formulations. The company maintains a global footprint, supplying specialized biological solutions to a broad international client base.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a notification about an upcoming conference call to discuss the un-audited financial results for the quarter and half year ended September 30, 2024. It is an intimation letter sent to stock exchanges and does not contain the actual financial results or detailed transcript of the call. The document length is 2834 characters, which is relatively short and primarily serves as an announcement of the conference call event. Therefore, it is not the earnings release itself nor the call transcript, but an announcement related to the call. According to the classification rules, such announcements about conference calls are best classified as Regulatory Filings (RNS) since they do not fit other categories and are regulatory disclosures under SEBI regulations.
2024-11-04 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2024-10-30 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a short notice informing about the scheduling of a Board Meeting to consider and approve the unaudited financial results for the quarter and half year ended September 30, 2024. It also mentions the closure of the trading window. The document does not contain any financial data or results itself, nor does it include detailed financial statements or analysis. It is an announcement of an upcoming event (Board Meeting) and related procedural information. The document length is only 1477 characters, which is quite short and consistent with an announcement rather than a full report. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2024-10-30 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, confirming dematerialisation activities for the quarter ended September 30, 2024. It is a compliance certificate issued by the Registrar and Transfer Agent to the company and stock exchanges. The document is short (2696 characters) and primarily serves as a regulatory compliance confirmation rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or detailed financial data. It is not an announcement of a report but a certificate confirming regulatory compliance. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance certificates and miscellaneous regulatory documents.
2024-10-10 English
Allotment of Securities
Share Issue/Capital Change Classification · 100% confidence The document is a formal notification from the company about the allotment of equity shares under an Employee Stock Options Scheme. It details the number of shares allotted, the increase in paid-up share capital, and confirms that the shares rank pari-passu with existing shares. There is no financial statement or detailed financial analysis, but rather an announcement of a change in the company's capital structure due to share allotment. This fits the definition of a Share Issue/Capital Change filing, which covers announcements regarding new share issues or capital changes.
2024-10-02 English
Action(s) taken or orders passed
Regulatory Filings Classification · 95% confidence The document is an intimation letter addressed to stock exchanges regarding an order received from the Income Tax Department. It references regulatory compliance under SEBI Listing Obligations and Disclosure Requirements, specifically Regulation 30 and Schedule III, which pertain to disclosure of material events. The document details the nature of the order, dates, and impact but does not contain financial statements or detailed financial analysis. It is a regulatory announcement about a legal/tax matter rather than a full legal proceedings report or audit report. Given the nature and length (2586 characters), it is a regulatory filing notifying the market of a material event. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2024-10-01 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.